Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hagedorn

Showing results (151-160 of 261) with videos related to

Pageof 27
Sort By:
Pain Practice : the Official Journal of World Institute of Pain|May 31, 2023
Percutaneous image-guided lumbar decompression and interspinous spacers for the treatment of lumbar spinal stenosis: A 2-year Medicare Claims Benchmark StudyPeter S Staats, Jonathan M Hagedorn, David E Reece, et al.
Pain Practice : the Official Journal of World Institute of Pain|July 13, 2020
Effect of Patient Characteristics on Reported Outcomes Over 12 Months Following Lumbar Radiofrequency Ablation: A Retrospective Review of 500 PatientsAbhishek Yadav, Jonathan M Hagedorn, Ryan S D'Souza, et al.
Journal of Pain Research|October 28, 2022
Spinal Cord Stimulation in Special Populations: Best Practices from the American Society of Pain and Neuroscience to Improve Safety and EfficacyJennifer M Lee, David Lee, Sandy Christiansen, et al.
Neuromodulation : Journal of the International Neuromodulation Society|March 14, 2022
Comparison of Spinal Cord Stimulation Trial Reporting Protocols and Long-Term Pain Relief Outcomes Following ImplantationJonathan M Hagedorn, Markus A Bendel, Alexander Schmidt, et al.
Pain Management|May 20, 2020
Proclaim™ DRG Neurostimulator System for the management of chronic, intractable painJonathan M Hagedorn, Pavli S Demian, Keith-Austin Scarfo, et al.
Journal of Medical Genetics|February 4, 2005
Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndromeM Meins, J Lehmann, F Gerresheim, et al.
Pain Physician|May 16, 2023
A Retrospective Review of Real-world Outcomes Following 60-day Peripheral Nerve Stimulation for the Treatment of Chronic PainMarc A Huntoon, Konstantin V Slavin, Jonathan M Hagedorn, et al.
Journal of Pain Research|December 16, 2020
Current Perspectives on Spinal Cord Stimulation for the Treatment of Cancer PainJonathan M Hagedorn, Thomas P Pittelkow, Christine L Hunt, et al.
Neuromodulation : Journal of the International Neuromodulation Society|July 8, 2022
The Prevalence of Elevated Impedances and Magnetic Resonance Imaging Ineligibility Following Implantation of 10 kHz Spinal Cord Stimulation Devices: A Retrospective ReviewJonathan M Hagedorn, James B Parmele, Jason S Wolff, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 24, 1999
Integrin-binding peptides derived from phage display librariesE Koivunen, B H Restel, D Rajotte, et al.
Pageof 27

Showing results (151-160 of 261) with videos related to

Sort By:
Pageof 27
Pain Practice : the Official Journal of World Institute of Pain|May 31, 2023
Percutaneous image-guided lumbar decompression and interspinous spacers for the treatment of lumbar spinal stenosis: A 2-year Medicare Claims Benchmark StudyPeter S Staats, Jonathan M Hagedorn, David E Reece, et al.
Pain Practice : the Official Journal of World Institute of Pain|July 13, 2020
Effect of Patient Characteristics on Reported Outcomes Over 12 Months Following Lumbar Radiofrequency Ablation: A Retrospective Review of 500 PatientsAbhishek Yadav, Jonathan M Hagedorn, Ryan S D'Souza, et al.
Journal of Pain Research|October 28, 2022
Spinal Cord Stimulation in Special Populations: Best Practices from the American Society of Pain and Neuroscience to Improve Safety and EfficacyJennifer M Lee, David Lee, Sandy Christiansen, et al.
Neuromodulation : Journal of the International Neuromodulation Society|March 14, 2022
Comparison of Spinal Cord Stimulation Trial Reporting Protocols and Long-Term Pain Relief Outcomes Following ImplantationJonathan M Hagedorn, Markus A Bendel, Alexander Schmidt, et al.
Pain Management|May 20, 2020
Proclaim™ DRG Neurostimulator System for the management of chronic, intractable painJonathan M Hagedorn, Pavli S Demian, Keith-Austin Scarfo, et al.
Journal of Medical Genetics|February 4, 2005
Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndromeM Meins, J Lehmann, F Gerresheim, et al.
Pain Physician|May 16, 2023
A Retrospective Review of Real-world Outcomes Following 60-day Peripheral Nerve Stimulation for the Treatment of Chronic PainMarc A Huntoon, Konstantin V Slavin, Jonathan M Hagedorn, et al.
Journal of Pain Research|December 16, 2020
Current Perspectives on Spinal Cord Stimulation for the Treatment of Cancer PainJonathan M Hagedorn, Thomas P Pittelkow, Christine L Hunt, et al.
Neuromodulation : Journal of the International Neuromodulation Society|July 8, 2022
The Prevalence of Elevated Impedances and Magnetic Resonance Imaging Ineligibility Following Implantation of 10 kHz Spinal Cord Stimulation Devices: A Retrospective ReviewJonathan M Hagedorn, James B Parmele, Jason S Wolff, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 24, 1999
Integrin-binding peptides derived from phage display librariesE Koivunen, B H Restel, D Rajotte, et al.
Pageof 27